Spontaneous Mutations in the HBV Genome and their Clinical Implications Pejman G. MansourianMarc G. GhanyEmmanuel Thomas Hepatitis B: Therapeutics (P Martin and WG Cooksley, Section Editors) 21 April 2013 Pages: 79 - 87
Response Guided Treatment for Peginterferon in Chronic Hepatitis B P. ArendsH. L. A. Janssen Hepatitis B: Therapeutics (P Martin and WG Cooksley, Section Editors) 07 April 2013 Pages: 88 - 95
Resistance is no Longer a Problem with Entecavir and Tenofovir Seng Gee LimGuan Huei LeePoh Seng Tan Hepatitis B: Therapeutics (P Martin and WG Cooksley, Section Editors) 04 April 2013 Pages: 96 - 104
Stopping Therapy in HBeAg Negative Disease Weng Kai ChanSoek-Siam TanRosmawati Mohamed Hepatitis B: Therapeutics (P Martin and WG Cooksley, Section Editors) 24 March 2013 Pages: 105 - 111
Occult Hepatitis B Virus (HBV) Infections: Hepatitis B Surface Antigen (HBsAg) Negative and Primary Occult Ferruccio BoninoMaurizia Rossana Brunetto Hepatitis B: Therapeutics (P Martin and WG Cooksley, Section Editors) 10 April 2013 Pages: 112 - 118
Current Management of HBV Pre and Post Liver Transplant Geoffrey W. McCaughan Hepatitis B: Therapeutics (P Martin and WG Cooksley, Section Editors) 25 May 2013 Pages: 119 - 123
Hepatitis B Virus Genotypes: Clinical Relevance and Therapeutic Implications Chih-Lin LinJia-Horng Kao Hepatitis B: Therapeutics (P Martin and WG Cooksley, Section Editors) 06 April 2013 Pages: 124 - 132